Debate: Optimal approach for stage III NSCLC - Trimodality therapy

Debate: Optimal approach for stage III NSCLC - Trimodality therapy

HMP CME

2 years
527 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Paul Van Schil arguest that trimodality therapy is the optimal approach for stage III non-small cell lung cancer (NSCLC). Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=Lung © 2017 Imedex, LLC.
Up Next Autoplay